Clinical Biosafety Services, a subsidiary of Sabai Global

Biotechnology ResearchMissouri, United States11-50 Employees

Gene Therapy.  Accelerated.  

Clinical Biosafety Services provides Institutional Biosafety Committee (IBC) Review and Biosafety Consulting Services.

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor. Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.

Sign up for free to view info

Email Format Employee directory